Peer-Reviewed Articles


  1. Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A4-Mediated Metabolism of Saxagliptin
    M. A. Butrovich, W. Tang, D. W. Boulton, and 2 more authors
    J Clin Pharmacol Aug 2022


  1. Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants
    M. A. Casal, S. P. Ivy, J. H. Beumer, and 1 more author
    Lancet Oncol Sep 2021


  1. Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing
    M. A. Casal, T. D. Nolin, and J. H. Beumer
    Clin J Am Soc Nephrol Apr 2019


  1. CINPA1 binds directly to constitutive androstane receptor and inhibits its activity
    M. T. Cherian, S. C. Chai, W. C. Wright, and 7 more authors
    Biochem Pharmacol Jun 2018


  1. Disruption of SUMO-targeted ubiquitin ligases Slx5-Slx8/RNF4 alters RecQ-like helicase Sgs1/BLM localization in yeast and human cells
    S. Böhm, M. J. Mihalevic, M. A. Casal, and 1 more author
    DNA Repair (Amst) Feb 2015

Book Chapters


  1. Personalized Pharmacotherapy for Patients with Chronic Kidney Disease
    M. A. Butrovich, and T. D. Nolin